Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

493 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicine.
Weidmann E, Boehrer S, Chow KU, Engels K, Harder L, Hinz T, Janssen O, Kriener S, Rummel MJ, Siebert R, Kabelitz D, Hansmann ML, Hoelzer D, Mitrou PS; Study Group Peripheral T- and NK-Cell Neoplasias. Weidmann E, et al. Among authors: hansmann ml. Onkologie. 2001 Apr;24(2):162-4. doi: 10.1159/000050305. Onkologie. 2001. PMID: 11441297
[Pancytopenia, hepatosplenomegaly and fever in a 49-year old patient].
Wassmann B, Seipelt G, Länger F, Rummel M, Böhme A, Hansmann ML, Hoelzer D. Wassmann B, et al. Among authors: hansmann ml. Internist (Berl). 2000 Mar;41(3):304-8. doi: 10.1007/s001080050507. Internist (Berl). 2000. PMID: 10789094 German. No abstract available.
LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting.
Thurner L, Hartmann S, Fadle N, Kemele M, Bock T, Bewarder M, Regitz E, Neumann F, Nimmesgern A, von Müller L, Pott C, Kim YJ, Bohle RM, Wasik M, Schuster SJ, Hansmann ML, Preuss KD, Pfreundschuh M. Thurner L, et al. Among authors: hansmann ml. Leukemia. 2019 Jan;33(1):148-158. doi: 10.1038/s41375-018-0182-1. Epub 2018 Jun 28. Leukemia. 2019. PMID: 29955130
Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group.
Eichenauer DA, Plütschow A, Fuchs M, Hartmann S, Hansmann ML, Böll B, von Tresckow B, Borchmann P, Engert A. Eichenauer DA, et al. Among authors: hansmann ml. Leukemia. 2020 Mar;34(3):953-956. doi: 10.1038/s41375-019-0609-3. Epub 2019 Oct 21. Leukemia. 2020. PMID: 31636342 Clinical Trial. No abstract available.
493 results